BioMedix Vascular Solutions, Inc. today announced expanded testing capabilities for its award-winning vascular diagnostic system with the release of PADnet+ Segmental Pressures to measure blood pressure at additional levels on the legs.
September is National Peripheral Arterial Disease (P.A.D.) Awareness Month. This month, BioMedix Vascular Solutions, Inc. is working with partners to raise awareness of Peripheral Arterial Disease (P.A.D.).
In partnership with the Ecole Centrale, in Paris, Edgar Hardy, CEO of Solar 21, has developed Mona, an LED solar light which can be used in both domestic and commercial premises. The Mona light, which is portable, wireless, lightweight, easy to use, and capable of lighting a room of 15m˛, will be showcased at the World Climate Solutions trade show in Copenhagen (Denmark) from 29 September to 30 S.
Gene Logic, an Ocimum Biosolutions company, announces the appointment of Norrie J. W. Russell, Ph. D., as the President of the company. With more than 30 years of experience in drug discovery, Dr. Russell has a history of success driving innovation in pharmaceutical discovery and development. He has held leadership roles with NovaRx, Invitrogen, Aviva Biosciences and and Lynx Therapeutics.
International Stem Cell Corporation today announced that its stem cell therapeutic programs focused on protective, transparent corneas will be formalized into a new business unit called Cytovis™.
The first walk-in DNA Testing facility, DNA Diagnostic Centre UK confirms large numbers of families are being re-united through DNA immigration testing services.
International Stem Cell Corporation and Sankara Nethralaya Eye Hospital, a nonprofit medical facility, are collaborating to develop ISCO's 'CytoCor™' stem cell-derived corneal tissue. The goal is to use CytoCor, human tissue derived from pluripotent human stem cells, to treat corneal blindness and vision impairment.
Calibrate encourages InterMune's involvement with Bike 4 Breath, a charity bike ride hosted by Breathe California that helps raise funds to fight lung disease and promote clean air in the Bay Area.
Quick-Med will present the poster abstract “New BIOGUARD Antimicrobial Wound Dressing with Advanced NIMBUS Technology.” BIOGUARD™ dressings, which were introduced in June, are the first wound care products to feature the novel, FDA-cleared NIMBUS technology. They serve as a barrier to infection, kill germs absorbed into the dressing, and provide an optimum wound healing environment.
Newtechbio, Inc. announced today that it has expanded its product offering line with the addition of Bed Bug Mace to control and get rid of bed bug infestations in residential, hospitality, commercial and industrial buildings. Bed Bug Mace kits contain powerful EPA GRAS list ingredients along with EPA approved Diatomaceous Earth (DE) for immediate and extended control.
Announcing the release of ExpressID AFIS v1.30 - Building upon its award winning fingerprint analysis and matching technologies, Innovatrics is proud to announce ExpressID AFIS v1.30.
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report detailing the huge support the biofuel industry receives from the Indian government in form of incentives, tax exemptions, favourable policies etc. Other factors contributing to the success of the biofuel industry in the country are also focused upon in the report.
Satisfied Users & 
Approved Press Releases
